Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00306930 · ClinicalTrials.gov registry record · NA

Clinical Study Evaluating an Acetabular Cup System After Total Hip Replacement

A NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by DePuy Orthopaedics.

Completed
Registry status
NA
Development phase
1,593
Enrollment target
1
Study location

NCT00306930: Completed NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by DePuy Orthopaedics.

NCT00306930 is a NA study of Rheumatoid Arthritis and Osteoarthritis that has completed, run by DePuy Orthopaedics. The registered enrollment target is 1,593 participants, below the 4,683-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00306930, a NA study of Rheumatoid Arthritis and Osteoarthritis, has completed, sponsored by DePuy Orthopaedics.

COMPLETED
Registry status
NA
Development phase
1,593 participants
Enrollment target
1
Study location

Study Summary

This study is a clinical evaluation of survivorship of an acetabular cup system after total hip replacement using patient examinations and questionnaires.

Interventions

  • DEVICE Acetabular cup

Study Locations (1)

Indiana

  • DePuy Orthopaedics - Warsaw

Trial Details

FieldValue
Enrollment Target 1,593 participants
Start Date 2000-07
Est. Completion 2012-12
Phase NA
DePuy Orthopaedics

38 total trials

What the finished NCT00306930 record still lists

NCT00306930 is an interventional study that assigns participants to a tested intervention. Its 1,593 participants enrollment target places it among the larger protocols in the corpus, below the 4,683-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (66% lower).

The record links to 5 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Acetabular cup is the first listed.

NCT00306930 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT00306930 about?

NCT00306930 is a clinical study titled "Clinical Study Evaluating an Acetabular Cup System After Total Hip Replacement". This study is a clinical evaluation of survivorship of an acetabular cup system after total hip replacement using patient examinations and questionnaires.

What is the current status of trial NCT00306930?

This trial is currently completed. It is a NA study. The enrollment target is 1,593 participants. The study started on 2000-07. Estimated completion is 2012-12.

What conditions does trial NCT00306930 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Arthritis, Avascular Necrosis, Acute Fracture.

What interventions are being tested in trial NCT00306930?

The interventions under investigation include: Acetabular cup (DEVICE).

Who is sponsoring clinical trial NCT00306930?

This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00306930 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00306930's enrollment target sits among peer trials

1,593 15th of 197 higher than 183 of 197 other Rheumatoid Arthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05243797 · 1,594 participants · Phase 3

    Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

  • NCT05552222 · 1,590 participants · Phase 3

    A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

  • NCT06632457 · 1,590 participants · Phase 3

    LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  • NCT00646022 · 1,600 participants

    Natural History of Familial Carcinoid Tumor

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00306930, the US trial registry maintained by the National Library of Medicine. NCT00306930 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.